DM

Deerfield Management Portfolio holdings

AUM $5.51B
This Quarter Return
+12.57%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.11B
AUM Growth
+$4.11B
Cap. Flow
-$2.19M
Cap. Flow %
-0.05%
Top 10 Hldgs %
37.55%
Holding
126
New
30
Increased
16
Reduced
24
Closed
24

Sector Composition

1 Healthcare 62.18%
2 Financials 1.23%
3 Industrials 0.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SIEN
76
DELISTED
Sientra, Inc.
SIEN
$7.89M 0.19%
232,022
-184,258
-44% -$6.26M
STIM icon
77
Neuronetics
STIM
$208M
$7.66M 0.19%
1,575,000
-118,317
-7% -$575K
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.35M 0.18%
628,139
-216,861
-26% -$2.54M
OM icon
79
Outset Medical
OM
$245M
$6.25M 0.15%
+8,333
New +$6.25M
PANA.U
80
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$6M 0.15%
+500,000
New +$6M
AERI
81
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$5.82M 0.14%
494,216
TSHA icon
82
Taysha Gene Therapies
TSHA
$791M
$5.6M 0.14%
+250,000
New +$5.6M
ARYBU
83
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$5.5M 0.13%
500,000
CABA icon
84
Cabaletta Bio
CABA
$144M
$5.03M 0.12%
464,252
GNMK
85
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.5M 0.06%
+175,806
New +$2.5M
VKTX icon
86
Viking Therapeutics
VKTX
$3.02B
$2.03M 0.05%
+348,441
New +$2.03M
MNK
87
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.92M 0.05%
1,970,687
PMVP icon
88
PMV Pharmaceuticals
PMVP
$82.1M
$1.78M 0.04%
+50,000
New +$1.78M
CERS icon
89
Cerus
CERS
$251M
$533K 0.01%
85,143
-2,119,557
-96% -$13.3M
ALIM
90
DELISTED
Alimera Sciences, Inc.
ALIM
$332K 0.01%
+68,413
New +$332K
NEOS
91
DELISTED
Neos Therapeutics, Inc
NEOS
$170K ﹤0.01%
320,993
WINT
92
DELISTED
Windtree Therapeutics
WINT
0
-$141K
APLT icon
93
Applied Therapeutics
APLT
$73.7M
-278,359
Closed -$10.1M
DBVT
94
DBV Technologies
DBVT
$249M
-515,416
Closed -$22.6M
FOLD icon
95
Amicus Therapeutics
FOLD
$2.42B
-1,416,000
Closed -$21.4M
KROS icon
96
Keros Therapeutics
KROS
$638M
-300,000
Closed -$11.3M
MCK icon
97
McKesson
MCK
$85.9B
-278,085
Closed -$42.7M
ORIC icon
98
Oric Pharmaceuticals
ORIC
$1.03B
-300,000
Closed -$10.1M
RCKT icon
99
Rocket Pharmaceuticals
RCKT
$358M
-53,043
Closed -$1.11M
SDGR icon
100
Schrodinger
SDGR
$1.42B
-1,346,167
Closed -$123M